Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
dofetilide potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank , DGIDB Atrial Fibrillation[MeSHID:D001281]
Recurrence (disease attribute)[MeSHID:D012008]
Maintenance[MeSHID:D008283]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.23 approved,investigational inhibitor
dofetilide potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank , DGIDB Atrial Fibrillation[MeSHID:D001281]
Recurrence (disease attribute)[MeSHID:D012008]
Maintenance[MeSHID:D008283]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.23 approved,investigational inhibitor,blocker
dofetilide atp-sensitive inward rectifier potassium channel 12 small molecule NA drugbank , DGIDB Atrial Fibrillation[MeSHID:D001281]
Recurrence (disease attribute)[MeSHID:D012008]
Maintenance[MeSHID:D008283]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 15.91 approved,investigational inhibitor
dofetilide potassium channel subfamily k member 2 small molecule NA drugbank , DGIDB Atrial Fibrillation[MeSHID:D001281]
Recurrence (disease attribute)[MeSHID:D012008]
Maintenance[MeSHID:D008283]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 2.65 approved,investigational inhibitor
click here to return to the previous page